Bacteriostatic and bactericidal activity of rabeprazole against Helicobacter pylori.
Garza-González
E
E
Tijerina-Menchaca
R
R
Pérez-Pérez
G I
GI
Bosques-Padilla
F J
FJ
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D001562:Benzimidazoles / Q000494:pharmacology*; D004415:Dyspepsia / Q000382:microbiology; D005260:Female; D016480:Helicobacter pylori / Q000187:drug effects* / Q000302:isolation & purification / Q000472:pathogenicity*; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009853:Omeprazole / Q000031:analogs & derivatives* / Q000494:pharmacology*; D064750:Rabeprazole
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D001562:Benzimidazoles; D064750:Rabeprazole; D009853:Omeprazole